"Stavudine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV.
Descriptor ID |
D018119
|
MeSH Number(s) |
D03.383.742.680.705.875 D13.570.230.500.850 D13.570.230.855.875 D13.570.685.705.875
|
Concept/Terms |
Stavudine- Stavudine
- D4T
- 2',3'-Didehydro-3'-deoxythymidine
- 2',3' Didehydro 3' deoxythymidine
- 2',3'-Didehydro-2',3'-dideoxythmidine
|
Below are MeSH descriptors whose meaning is more general than "Stavudine".
Below are MeSH descriptors whose meaning is more specific than "Stavudine".
This graph shows the total number of publications written about "Stavudine" by people in this website by year, and whether "Stavudine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2004 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
2017 | 1 | 3 | 4 |
2018 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Stavudine" by people in Profiles.
-
Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19. Eur J Pharmacol. 2021 Jan 05; 890:173720.
-
A library of nucleotide analogues terminate RNA synthesis catalyzed by polymerases of coronaviruses that cause SARS and COVID-19. Antiviral Res. 2020 08; 180:104857.
-
Comparative safety and effectiveness of perinatal antiretroviral therapies for HIV-infected women and their children: Systematic review and network meta-analysis including different study designs. PLoS One. 2018; 13(6):e0198447.
-
Community outreach programs and major adherence lapses with antiretroviral therapy in rural Kakamega, Kenya. AIDS Care. 2018 06; 30(6):696-700.
-
Predictors of HIV virological failure and drug resistance in Chinese patients after 48 months of antiretroviral treatment, 2008-2012: a prospective cohort study. BMJ Open. 2017 Sep 07; 7(9):e016012.
-
[Obesity, high blood pressure, hypercholesterolaemia, and untreated diabetes in HIV-infected and HIV-uninfected Adults in Mbuji-Mayi (Democratic republic of congo)]. Bull Soc Pathol Exot. 2017 Dec; 110(5):301-309.
-
Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy. PLoS One. 2017; 12(6):e0178942.
-
SAMHD1 has differential impact on the efficacies of HIV nucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother. 2014 Aug; 58(8):4915-9.
-
NNRTI-selected mutations at codon 190 of human immunodeficiency virus type 1 reverse transcriptase decrease susceptibility to stavudine and zidovudine. Antiviral Res. 2007 Nov; 76(2):99-103.
-
A case of lactic acidosis caused by stavudine in an AIDS patient. Korean J Intern Med. 2004 Mar; 19(1):66-9.